Literature DB >> 24002588

CBFB-MYH11/RUNX1 together with a compendium of hematopoietic regulators, chromatin modifiers and basal transcription factors occupies self-renewal genes in inv(16) acute myeloid leukemia.

A Mandoli1, A A Singh1, P W T C Jansen2, A T J Wierenga3, H Riahi1, G Franci4, K Prange1, S Saeed1, E Vellenga5, M Vermeulen2, H G Stunnenberg1, J H A Martens1.   

Abstract

Different mechanisms for CBFβ-MYH11 function in acute myeloid leukemia with inv(16) have been proposed such as tethering of RUNX1 outside the nucleus, interference with transcription factor complex assembly and recruitment of histone deacetylases, all resulting in transcriptional repression of RUNX1 target genes. Here, through genome-wide CBFβ-MYH11-binding site analysis and quantitative interaction proteomics, we found that CBFβ-MYH11 localizes to RUNX1 occupied promoters, where it interacts with TAL1, FLI1 and TBP-associated factors (TAFs) in the context of the hematopoietic transcription factors ERG, GATA2 and PU.1/SPI1 and the coregulators EP300 and HDAC1. Transcriptional analysis revealed that upon fusion protein knockdown, a small subset of the CBFβ-MYH11 target genes show increased expression, confirming a role in transcriptional repression. However, the majority of CBFβ-MYH11 target genes, including genes implicated in hematopoietic stem cell self-renewal such as ID1, LMO1 and JAG1, are actively transcribed and repressed upon fusion protein knockdown. Together these results suggest an essential role for CBFβ-MYH11 in regulating the expression of genes involved in maintaining a stem cell phenotype.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24002588     DOI: 10.1038/leu.2013.257

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  46 in total

1.  Establishment and characterization of a new human leukemia cell line derived from M4E0.

Authors:  K Yanagisawa; T Horiuchi; S Fujita
Journal:  Blood       Date:  1991-07-15       Impact factor: 22.113

2.  The Notch ligand, Jagged-1, influences the development of primitive hematopoietic precursor cells.

Authors:  B Varnum-Finney; L E Purton; M Yu; C Brashem-Stein; D Flowers; S Staats; K A Moore; I Le Roux; R Mann; G Gray; S Artavanis-Tsakonas; I D Bernstein
Journal:  Blood       Date:  1998-06-01       Impact factor: 22.113

3.  SnapShot: Acute myeloid leukemia.

Authors:  Bernd B Zeisig; Austin G Kulasekararaj; Ghulam J Mufti; Chi Wai Eric So
Journal:  Cancer Cell       Date:  2012-11-13       Impact factor: 31.743

4.  Rapid identification of CBFB-MYH11-positive acute myeloid leukemia (AML) cases by one single MYH11 real-time RT-PCR.

Authors:  Bert A van der Reijden; Marion Massop; Evelyn Tönnissen; Louis van de Locht; Petra Muus; Theo de Witte; Joop H Jansen
Journal:  Blood       Date:  2003-06-15       Impact factor: 22.113

5.  AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis.

Authors:  T Okuda; J van Deursen; S W Hiebert; G Grosveld; J R Downing
Journal:  Cell       Date:  1996-01-26       Impact factor: 41.582

6.  The leukemic protein core binding factor beta (CBFbeta)-smooth-muscle myosin heavy chain sequesters CBFalpha2 into cytoskeletal filaments and aggregates.

Authors:  N Adya; T Stacy; N A Speck; P P Liu
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

7.  Identification of genes that synergize with Cbfb-MYH11 in the pathogenesis of acute myeloid leukemia.

Authors:  L H Castilla; P Perrat; N J Martinez; S F Landrette; R Keys; S Oikemus; J Flanegan; S Heilman; L Garrett; A Dutra; S Anderson; G A Pihan; L Wolff; P P Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-24       Impact factor: 11.205

8.  The inv(16) fusion protein associates with corepressors via a smooth muscle myosin heavy-chain domain.

Authors:  Kristie L Durst; Bart Lutterbach; Tanawan Kummalue; Alan D Friedman; Scott W Hiebert
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

9.  Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding.

Authors:  A Ptasinska; S A Assi; D Mannari; S R James; D Williamson; J Dunne; M Hoogenkamp; M Wu; M Care; H McNeill; P Cauchy; M Cullen; R M Tooze; D G Tenen; B D Young; P N Cockerill; D R Westhead; O Heidenreich; C Bonifer
Journal:  Leukemia       Date:  2012-02-20       Impact factor: 11.528

10.  Enhancer decommissioning by LSD1 during embryonic stem cell differentiation.

Authors:  Warren A Whyte; Steve Bilodeau; David A Orlando; Heather A Hoke; Garrett M Frampton; Charles T Foster; Shaun M Cowley; Richard A Young
Journal:  Nature       Date:  2012-02-01       Impact factor: 49.962

View more
  36 in total

1.  CBFβ-SMMHC Inhibition Triggers Apoptosis by Disrupting MYC Chromatin Dynamics in Acute Myeloid Leukemia.

Authors:  John Anto Pulikkan; Mahesh Hegde; Hafiz Mohd Ahmad; Houda Belaghzal; Anuradha Illendula; Jun Yu; Kelsey O'Hagan; Jianhong Ou; Carsten Muller-Tidow; Scot A Wolfe; Lihua Julie Zhu; Job Dekker; John Hackett Bushweller; Lucio Hernán Castilla
Journal:  Cell       Date:  2018-06-28       Impact factor: 41.582

2.  CBFβ-SMMHC regulates ribosomal gene transcription and alters ribosome biogenesis.

Authors:  G Cordonnier; A Mandoli; A Radhouane; G Hypolite; L Lhermitte; M Belhocine; V Asnafi; E Macintyre; J H A Martens; S Fumagalli; J Bond
Journal:  Leukemia       Date:  2017-02-15       Impact factor: 11.528

3.  Pharmacological inhibition of aberrant transcription factor complexes in inversion 16 acute myeloid leukemia.

Authors:  Sandeep Potluri; Daniel Coleman; Constanze Bonifer
Journal:  Stem Cell Investig       Date:  2018-09-30

Review 4.  The RUNX1-PU.1 axis in the control of hematopoiesis.

Authors:  Maria Rosaria Imperato; Pierre Cauchy; Nadine Obier; Constanze Bonifer
Journal:  Int J Hematol       Date:  2015-03-08       Impact factor: 2.490

5.  HDAC1 Is a Required Cofactor of CBFβ-SMMHC and a Potential Therapeutic Target in Inversion 16 Acute Myeloid Leukemia.

Authors:  Lisa E Richter; Yiqian Wang; Michelle E Becker; Rachel A Coburn; Jacob T Williams; Catalina Amador; R Katherine Hyde
Journal:  Mol Cancer Res       Date:  2019-02-27       Impact factor: 5.852

6.  The transcriptional corepressor CBFA2T3 inhibits all-trans-retinoic acid-induced myeloid gene expression and differentiation in acute myeloid leukemia.

Authors:  Nickolas Steinauer; Chun Guo; Jinsong Zhang
Journal:  J Biol Chem       Date:  2020-05-20       Impact factor: 5.157

7.  Developmental Control of NRAMP1 (SLC11A1) Expression in Professional Phagocytes.

Authors:  Mathieu F M Cellier
Journal:  Biology (Basel)       Date:  2017-05-03

8.  RUNX1 and CBFβ-SMMHC transactivate target genes together in abnormal myeloid progenitors for leukemia development.

Authors:  Tao Zhen; Yaqiang Cao; Gang Ren; Ling Zhao; R Katherine Hyde; Guadalupe Lopez; Dechun Feng; Lemlem Alemu; Keji Zhao; P Paul Liu
Journal:  Blood       Date:  2020-11-19       Impact factor: 22.113

9.  Helicase-like transcription factor is a RUNX1 target whose downregulation promotes genomic instability and correlates with complex cytogenetic features in acute myeloid leukemia.

Authors:  Chi Keung Cheng; Natalie P H Chan; Thomas S K Wan; Lai Ying Lam; Coty H Y Cheung; Terry H Y Wong; Rosalina K L Ip; Raymond S M Wong; Margaret H L Ng
Journal:  Haematologica       Date:  2016-01-22       Impact factor: 9.941

10.  MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML.

Authors:  N S D Larmonie; T C J M Arentsen-Peters; A Obulkasim; D Valerio; E Sonneveld; A A Danen-van Oorschot; V de Haas; D Reinhardt; M Zimmermann; J Trka; A Baruchel; R Pieters; M M van den Heuvel-Eibrink; C M Zwaan; M Fornerod
Journal:  Oncogene       Date:  2017-09-11       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.